Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO)

NCT06114940 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
17
Enrollment
OTHER
Sponsor class

Stopped Involving changes to the primary endpoint, it is difficult to unify the evaluation criteria for subjects' endpoints before and after the change.

Conditions

Interventions

Sponsor

Jinling Hospital, China